GlassScriptPhysician profile
Jared G Winters
NPI 1154680338
$5,102.50
in general payments reported to CMS, 2019-2025
15 companies · $1,835 in 2025
The $1,835 reported for 2025 was more than what 99% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $208 · 2022: $201 · 2023: $1,223 · 2024: $1,634 · 2025: $1,835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,653 · Education: $39.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,653.20 |
| Education | $39.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,016.70 | 2022-2025 | Farapulse, Watchman Flx, Rhythmia Mapping System |
| Medtronic, INC. | $650.93 | 2021-2025 | Affera Mapping System, Pulseselect, Cardioblate Cryoflex |
| Edwards Lifesciences Corporation | $608.73 | 2023-2025 | Hemosphere, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $431.98 | 2021-2025 | Ensite, Ensite Precision, Aveir |
| Mindray Ds USA, INC. | $427.64 | 2021-2025 | A7 Anesthesia System, Na Electrode,Indirect,International, Patient Monitor |
| Biosense Webster, INC. | $357.78 | 2023-2025 | Carto 3 |
| Becton, Dickinson and Company | $197.82 | 2024-2025 | Hemosphere, Swan-Ganz |
| Merck Sharp & Dohme LLC | $118.64 | 2021-2025 | Bridion |
| Pacira Pharmaceuticals Incorporated | $67.10 | 2023-2025 | Iovera, Exparel |
| Angiodynamics, INC. | $62.98 | 2025 | Alphavac |
| Abiomed | $49.81 | 2023-2025 | Impella |
| Stryker Corporation | $45.24 | 2025 | Stryker |
| Cvrx, INC. | $27.22 | 2024-2025 | Barostim Neo System |
| Chiesi USA, INC. | $21.73 | 2023 | Cleviprex |
| Davol INC. | $18.20 | 2025 | Arista |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Winters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.